Skip to content

Minimal Invasive Surgery for Gastric Subepithelial Tumor

Different Approach of Minimal Invasive Surgery for Gastric Subepithelial Tumor From A Single-Center Experience

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05452265
Enrollment
194
Registered
2022-07-11
Start date
2013-01-01
Completion date
2021-12-31
Last updated
2022-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Subepithelial Tumor

Keywords

gastric subepithelial tumors, endoscopic resection, laparoscopic resection

Brief summary

The investigators conducted a retrospective study of those patients with gastric SETs receiving ER or LR at the operative theater in the single institution from January 2013 to December 2021. Medical records were retrospectively reviewed to define patient/tumor characteristics and operative outcomes.

Interventions

Complete resection of gastric SETs was recommended if the tumor size was \>2 cm, presence of malignant features, or if the patient was symptomatic, declined periodical surveillance, and preferred to undergo diagnostic and therapeutic resection.

Sponsors

Changhua Christian Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* patients with gastric subepithelial tumors * patients received minimal invasive surgery (endoscopy or laparoscopy) for tumor resection

Exclusion criteria

* patients had gastric anatomic changes due to previous surgery * patients converted open surgery

Design outcomes

Primary

MeasureTime frameDescription
Procedure durationduring the procedure/surgeryminutes of procedure time
Length of hospital stayupto one month after surgerydays of hospitalization
Rate of postoperative major complicationsupto one month after surgerycomplications required further intervention, clavien dindo classification upto Grade III

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026